The Biotech Startups Podcast

174 Episodo

1. 🧬 Doug Drysdale - Cybin - Part 2 | Deals Only Get Done in Person | Learning Financing Through a Company’s Hardship | Bureaucracy in the Workplace | How to Educate Yourself to Determine Good Licensin

   Publicado: 29/8/2024
2. 🧬 Doug Drysdale - Cybin - Part 1 | One Teacher Can Change Your Whole Perspective | The Forefront of the Human Genome Project | How Loss Taught Him Not to Take Life For Granted | Learning How to Be P

   Publicado: 26/8/2024
3. 🧬 Noam Solomon - Immunai - Part 4 | How Searching for Investors is Like Finding a Life Partner | Luck In Fundraising | The Optimal Features of the Immune System | The Advice to Take More Risks

   Publicado: 22/8/2024
4. 🧬 Noam Solomon - Immunai - Part 3 | Deciphering the Book That is the Human Immune System | Building Immunai’s Team | The Importance of Single Cell Multi-Omics | Big Pharma & Dancing With Gorillas

   Publicado: 19/8/2024
5. 🧬 Noam Solomon - Immunai - Part 2 | The Value of Attending Prestigious Institutions | Immunai’s Genesis | AI, Machine Learning, & Their Applications in the Life Sciences | Mapping the Human Immune Sy

   Publicado: 15/8/2024
6. 🧬 Noam Solomon - Immunai - Part 1 | Attending Undergrad at 14 Year Old | How Mathematics Can Make You a Lone Wolf | The Difference Between Noam’s Two PhDs | The Resilience Required for Entrepreneursh

   Publicado: 12/8/2024
7. 🧬 Shekhar Mitra - InnoPreneur & P&G - Part 4 | Finding Foundational Intrapreneurship at P&G | Early Innovation in Drug Discovery & Development | Community & Diversity Leadership in Arts & STEM

   Publicado: 8/8/2024
8. 🧬 Shekhar Mitra - InnoPreneur & P&G - Part 3 | The First Big Innovation Center in Asia | The Whole Work of Leadership | Noticeability Driven Through Technology | Developing Emotional Drivers

   Publicado: 5/8/2024
9. 🧬 Shekhar Mitra - InnoPreneur & P&G - Part 2 | Columbia & Yale: Collaborating with Top Physicists | Moving from Academia to Procter & Gamble | Navigating Challenges, Celebrating Successes | Leading C

   Publicado: 1/8/2024
10. 🧬 Shekhar Mitra - InnoPreneur & P&G - Part 1 | Growing Up in a Multigenerational Household | Undergraduate Experience at IIT | Groundbreaking Lab Research at Columbia | Diverse Experiences in New Yor

    Publicado: 29/7/2024
11. 🧬 Nathan Clark - Ganymede - Part 4 | Data Integration & Automation in the Life Sciences | Building a Technical Team & Go-To-Market Motion | Creating Efficient Data Infrastructures | Automating Comple

    Publicado: 25/7/2024
12. 🧬 Nathan Clark - Ganymede - Part 3 | Parallels Between Benchling & Salesforce | Getting Customers to Fully Buy-In | Managing the “Writhing Snake of Data” | Ganymede Achieves Escape Velocity Growth

    Publicado: 22/7/2024
13. 🧬 Nathan Clark - Ganymede - Part 2 | Moving from Goldman Sachs to Fintech | Exploring Product Management at Affirm | Leveraging Data & Building Tech Solutions| Impacting Scientific Progress at Bench

    Publicado: 18/7/2024
14. 🧬 Nathan Clark - Ganymede - Part 1 | Early Influence of Entrepreneurs | Developing Passions for Both Finance & Life Sciences | Fundamentals of Trading & Finances | Experiences & Opportunities at Gol

    Publicado: 15/7/2024
15. 🧬 David Li - Meliora Therapeutics - Part 4 | Mechanism Identification in Biotech | AI & ML in Drug Development | Creating a New Method for Drug Discovery | Fundraising for Meliora | Building a Foun

    Publicado: 11/7/2024
16. 🧬 David Li - Meliora Therapeutics - Part 3 | Developing a Blood-Based Lung Cancer Test | The Rifle-Shot Nature of Biotech | Software Vs. Biotech Product Market Fit | The Super Power all Startups Nee

    Publicado: 8/7/2024
17. 🧬 David Li - Meliora Therapeutics - Part 2 | From Finance to Biotech Entrepreneurship | Building Solid Teams & Navigating Market Dynamics | Lessons in Early-Stage Startups

    Publicado: 3/7/2024
18. 🧬 David Li - Meliora Therapeutics - Part 1 | Childhood in China and Kentucky | Early Opportunities in Research & Biology | Benefits of Dual Degrees | Experiences & Opportunities while Investment Ban

    Publicado: 1/7/2024
19. 🧬 Mark Kotter - bit.bio - Part 4 | Democratizing Access to Cells & the Evolution of bit.bio | A Financial Journey from Angel Investment to IPO | Building a Tech Bio Platform & Mark’s 10-Year Vision

    Publicado: 27/6/2024
20. 🧬 Mark Kotter - bit.bio - Part 3 | Success in Academia vs. Industry | Vital Things All Founders Should Know | The Importance of Company Culture | bit.bio & the Operating System of Life

    Publicado: 24/6/2024